외골격 로봇 시장 - 세계 시장 예측(2026-2032년)

The Exoskeleton Robots Market is projected to grow by USD 1,769.30 million at a CAGR of 17.27% by 2032.

Exoskeleton robots are moving from experimental assistive devices to practical wearable robotics systems used in rehabilitation, mobility assistance, industrial ergonomics, defense support, and worker safety. These powered and passive systems combine mechanical structures, sensors, actuators, control software, batteries, and human-machine interfaces to augment strength, support posture, restore movement, or reduce musculoskeletal strain. Demand is being shaped by verified demographic and health trends, including aging populations, the global burden of stroke and spinal cord injury, persistent workplace musculoskeletal disorders, and the need to improve safety and productivity in physically intensive tasks.

The exoskeleton robots industry is defined by strict safety requirements, clinical validation needs, ergonomics standards, reimbursement considerations, and rapid innovation in lightweight materials, soft robotics, edge computing, and artificial intelligence. Healthcare applications focus on gait training, neurorehabilitation, and personal mobility, while industrial exoskeleton robots are increasingly used in logistics, automotive manufacturing, construction, warehousing, and maintenance operations to reduce fatigue during repetitive lifting, overhead work, and prolonged standing. Defense and emergency response users are evaluating exoskeleton technologies for load carriage, endurance, and injury prevention, though operational reliability, power density, comfort, and user acceptance remain essential adoption factors.

Transformative Shifts in the Exoskeleton Robots Landscape

The exoskeleton robots landscape is being transformed by a shift from rigid, heavy, lab-based prototypes toward lighter, modular, sensor-rich systems designed for real-world use. Advances in carbon fiber composites, aluminum alloys, textile-based structures, compact electric actuators, and compliant joint mechanisms are improving wearability and reducing metabolic burden. Soft exosuits are gaining attention where comfort, portability, and natural movement are critical, particularly in rehabilitation, eldercare, and industrial ergonomics.

Healthcare adoption is increasingly linked to evidence-based rehabilitation pathways, where robotic gait training and assistive mobility devices can support repetitive, task-specific therapy. Industrial deployment is shifting from proof-of-concept trials to targeted use cases with measurable ergonomic benefits, especially for shoulder, back, and lower-limb support. At the same time, regulatory pathways, human factors engineering, cybersecurity for connected devices, battery safety, and clinician or worker training are becoming central to commercialization. The landscape is also influenced by interoperability with digital health platforms, workplace safety systems, and remote monitoring tools, enabling exoskeleton robots to become part of broader connected care and connected operations ecosystems.

Cumulative Impact of Artificial Intelligence on Exoskeleton Robots

Artificial intelligence is increasing the functional value of exoskeleton robots by enabling more adaptive assistance, improved intent detection, and personalized control. AI-enabled systems can analyze sensor inputs from inertial measurement units, pressure sensors, electromyography, joint encoders, and force sensors to interpret user motion patterns and adjust assistance in real time. This is particularly relevant in rehabilitation, where therapy intensity and gait support must align with a patient's progress, fatigue level, and neurological recovery stage.

In industrial settings, AI can help identify unsafe movement patterns, quantify ergonomic risk, and optimize assistive torque for specific tasks. Machine learning models are also being used to refine gait phase detection, balance assistance, predictive maintenance, and anomaly detection in wearable robotic systems. The cumulative impact of artificial intelligence is not limited to automation; it is improving human-robot synchronization, reducing training time, and supporting data-driven decision-making for clinicians, safety managers, and operations teams. However, AI integration also raises important requirements around explainability, validation across diverse body types, privacy of biomechanical data, and compliance with medical device and workplace safety regulations.

Key Regional Insights for Exoskeleton Robots

Asia-Pacific is a major center for exoskeleton robot development and adoption due to strong robotics capabilities, rapidly aging populations in several economies, and growing investment in advanced rehabilitation and manufacturing automation. Japan, South Korea, China, India, and Australia are supporting demand through healthcare modernization, robotics research, and industrial safety initiatives, while regional manufacturers and research institutions are advancing wearable robotics for mobility support, rehabilitation, and worker assistance. The region's large manufacturing base also creates practical use cases for industrial exoskeleton robots in assembly, logistics, warehousing, and repetitive manual handling.

North America remains a key region for clinical research, defense-oriented wearable robotics, rehabilitation technology adoption, and workplace ergonomics programs. The United States and Canada benefit from established medical device regulatory systems, advanced rehabilitation networks, occupational safety awareness, and strong university research activity in biomechanics and robotics. Latin America is an emerging adoption region, led by demand for rehabilitation access, injury prevention, and industrial productivity improvement in countries such as Brazil and Mexico, though cost sensitivity, service availability, and reimbursement limitations influence deployment pace.

Europe is characterized by strong medical device regulation, active rehabilitation research, and robust workplace safety culture. European healthcare systems and industrial employers are evaluating exoskeleton robots in clinical neurorehabilitation, eldercare, automotive production, logistics, and construction-related ergonomics. The Middle East is adopting advanced medical technologies and smart healthcare infrastructure, with demand linked to rehabilitation centers, defense modernization, and industrial safety in energy and infrastructure sectors. Africa is at an earlier stage of adoption, with opportunities centered on rehabilitation access, assistive mobility, local clinical capacity building, and partnerships that improve affordability, training, maintenance, and long-term device support.

Key Group Insights for Exoskeleton Robots

ASEAN is gaining relevance as a production and adoption cluster for exoskeleton robots because of expanding manufacturing activity, rising workplace safety awareness, and increasing investment in healthcare infrastructure. Countries in the group are well positioned for industrial exoskeleton use in electronics, automotive, logistics, and warehousing, while rehabilitation demand is supported by urban hospital modernization and growing interest in assistive technologies for mobility impairment and post-stroke recovery.

The GCC is prioritizing advanced healthcare, defense readiness, and workplace safety across energy, construction, aviation, logistics, and infrastructure sectors, creating opportunities for exoskeleton robots in rehabilitation, load support, and injury reduction. The European Union provides a highly structured environment for medical device compliance, worker protection, and robotics research, making it a critical region for clinical validation, ergonomic standards, responsible data governance, and safe deployment of wearable robotic systems.

BRICS economies combine large patient populations, expanding industrial workforces, and national interest in robotics, creating a broad base for healthcare and industrial applications. Adoption patterns vary across the group, with China and India emphasizing scale, domestic innovation, and affordability, while Brazil and South Africa offer growth potential through rehabilitation access and workplace safety programs. G7 countries remain influential in exoskeleton robot innovation because of advanced healthcare systems, aging demographics, defense research, and strong industrial automation ecosystems. NATO members are evaluating exoskeleton technologies for soldier load carriage, endurance, injury prevention, and medical rehabilitation, although operational testing, power supply, ruggedness, interoperability, and human factors remain decisive for defense use.

Key Country Insights for Exoskeleton Robots

The United States is a leading country for exoskeleton robots due to its advanced rehabilitation infrastructure, defense research, robotics engineering base, and focus on reducing workplace musculoskeletal injuries. Canada supports adoption through rehabilitation science, healthcare innovation, and occupational safety initiatives, while Mexico's role is strengthened by manufacturing activity, especially in automotive and industrial operations where ergonomic support can reduce fatigue and repetitive strain. Brazil is the most prominent Latin American country environment for wearable robotics applications, supported by demand for rehabilitation services, industrial productivity, and assistive mobility solutions.

In Europe, the United Kingdom emphasizes rehabilitation technology, robotics research, and workplace safety, while Germany stands out for industrial exoskeleton applications due to its advanced manufacturing base, automotive sector, and engineering expertise. France is active in medical rehabilitation, defense innovation, and workplace ergonomics, and Italy's aging population and manufacturing sectors support interest in healthcare and industrial exoskeleton systems. Spain is increasingly relevant for rehabilitation, eldercare, and occupational safety initiatives, while Russia's exoskeleton robot activity is linked to defense, rehabilitation research, and industrial applications, with adoption influenced by technology localization and procurement priorities.

China is advancing exoskeleton robots through robotics manufacturing, healthcare modernization, defense research, and a rapidly aging population. India presents long-term opportunity because of its large rehabilitation need, expanding hospital networks, industrial workforce, and growing engineering talent, though affordability and local service capacity are critical. Japan is one of the most mature environments for assistive robotics, driven by demographic aging, rehabilitation demand, and long-standing robotics expertise. Australia supports adoption through rehabilitation research, occupational safety programs, mining and logistics applications, and healthcare innovation. South Korea combines strong electronics, robotics, and healthcare capabilities, making it an important country for wearable robotics development, clinical rehabilitation, and industrial ergonomics.

Actionable Recommendations for Exoskeleton Robot Industry Leaders

Industry leaders should prioritize application-specific design rather than one-size-fits-all exoskeleton robots. Healthcare systems require validated clinical outcomes, therapist-friendly workflows, patient safety features, and compatibility with rehabilitation protocols, while industrial buyers need measurable reductions in fatigue, injury risk, and task strain. Vendors and adopters should build evidence through controlled trials, ergonomic assessments, usability studies, and long-term post-deployment monitoring.

Organizations should also strengthen regulatory and safety readiness early in product development, including risk management, human factors engineering, cybersecurity, battery safety, and biomechanical validation. Interoperability with hospital information systems, remote monitoring tools, and workplace safety platforms can increase long-term value. Leaders should invest in modular architectures, lightweight materials, AI-enabled personalization, and service models that include training, maintenance, fit assessment, cleaning protocols, and user support. Strategic partnerships with rehabilitation centers, occupational safety experts, universities, insurers, and government programs can accelerate trusted adoption without compromising compliance, privacy, or user safety.

Research Methodology

This executive summary is developed using a structured secondary research approach focused on verified and publicly available information from medical device regulatory bodies, occupational safety agencies, peer-reviewed robotics and rehabilitation studies, standards organizations, public health sources, defense technology references, and technical documentation related to wearable robotics. The methodology emphasizes triangulation across clinical, industrial, technological, and regional evidence to identify adoption drivers, barriers, application patterns, and innovation trends.

The research process evaluates exoskeleton robots across healthcare, industrial, defense, and assistive mobility use cases, with attention to device type, human-machine interaction, safety requirements, regulatory considerations, data protection, and regional adoption conditions. Insights are synthesized qualitatively and do not include market sizing, market share, or forecasting. The analysis focuses on data-backed trends such as aging demographics, musculoskeletal injury reduction, rehabilitation demand, robotics innovation, artificial intelligence integration, and workplace ergonomics.

Conclusion

Exoskeleton robots are becoming an important category within wearable robotics, combining assistive mobility, rehabilitation science, industrial ergonomics, and intelligent control systems. Their adoption is being shaped by measurable needs: improving rehabilitation outcomes, supporting aging populations, reducing workplace musculoskeletal strain, and enhancing human performance in demanding environments. The most successful deployments will be those that demonstrate safety, comfort, usability, and evidence-based value in specific real-world tasks.

As artificial intelligence, soft robotics, advanced sensors, and lightweight materials continue to mature, exoskeleton robots are expected to become more adaptive, personalized, and integrated into clinical and industrial workflows. Industry progress will depend on rigorous validation, responsible data use, regulatory compliance, and practical service models that support users over time. Stakeholders that align innovation with human-centered design, clinical evidence, and occupational safety priorities will be best positioned to advance the next phase of exoskeleton robot adoption.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. New Revenue Opportunities
• 3.5. Next-Generation Business Models
• 3.6. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Exoskeleton Robots Market, by Product Type

• 7.1. Introduction
• 7.2. Full Body
• 7.3. Lower Limb
• 7.4. Upper Limb

8. Exoskeleton Robots Market, by Technology

• 8.1. Introduction
• 8.2. Active
• 8.3. Passive

9. Exoskeleton Robots Market, by Actuation Mode

• 9.1. Introduction
• 9.2. Electric
• 9.3. Hydraulic
• 9.4. Pneumatic

10. Exoskeleton Robots Market, by Application

• 10.1. Introduction
• 10.2. Defense
  • 10.2.1. Bomb Disposal
  • 10.2.2. Load Carriage
  • 10.2.3. Soldier Augmentation
• 10.3. Industrial
  • 10.3.1. Manufacturing
  • 10.3.2. Material Handling
  • 10.3.3. Warehousing
• 10.4. Medical
  • 10.4.1. Rehabilitation
    • 10.4.1.1. Gait Training
    • 10.4.1.2. Physical Therapy
  • 10.4.2. Surgical Assistance
  • 10.4.3. Therapy
• 10.5. Personal Assistance
  • 10.5.1. Daily Living Support
  • 10.5.2. Mobility Assistance

11. Exoskeleton Robots Market, by Region

• 11.1. Asia-Pacific
• 11.2. Europe
• 11.3. North America
• 11.4. Latin America
• 11.5. Africa
• 11.6. Middle East

12. Exoskeleton Robots Market, by Group

• 12.1. NATO
• 12.2. G7
• 12.3. BRICS
• 12.4. European Union
• 12.5. ASEAN
• 12.6. GCC

13. Exoskeleton Robots Market, by Country

• 13.1. China
• 13.2. United States
• 13.3. Japan
• 13.4. India
• 13.5. Germany
• 13.6. United Kingdom
• 13.7. Australia
• 13.8. France
• 13.9. South Korea
• 13.10. Italy
• 13.11. Canada
• 13.12. Russia
• 13.13. Brazil
• 13.14. Mexico
• 13.15. Spain

14. Competitive Landscape

• 14.1. Market Share Analysis, 2025
• 14.2. FPNV Positioning Matrix, 2025
• 14.3. Market Concentration Analysis, 2025
  • 14.3.1. Concentration Ratio (CR)
  • 14.3.2. Herfindahl Hirschman Index (HHI)
• 14.4. Recent Developments & Impact Analysis, 2025
• 14.5. Product Portfolio Analysis, 2025
• 14.6. Benchmarking Analysis, 2025

15. Company Profiles

• 15.1. B-Temia Inc.
• 15.2. Bionik Laboratories Corp
• 15.3. Built In, Inc.
• 15.4. Comau S.p.A.
• 15.5. Cyberdyne Inc.
• 15.6. Daiya Industry Co., Ltd.
• 15.7. Ekso Bionics Holdings Inc.
• 15.8. Focal Meditech BV
• 15.9. Hocoma AG
• 15.10. Honda Motor Co. Ltd.
• 15.11. Hyundai Motor Company
• 15.12. Levitate Technologies
• 15.13. Lockheed Martin Corporation
• 15.14. Mitsubishi Heavy Industries, Ltd.
• 15.15. Myomo Inc.
• 15.16. noonee germany GmbH
• 15.17. P&S Mechanics Co., Ltd.
• 15.18. Panasonic Holdings Corporation
• 15.19. Parker Hannifin Corporation
• 15.20. ReWalk Robotics Ltd
• 15.21. Roam Robotics
• 15.22. Schweiz AG
• 15.23. Toyota Motor Corporation
• 15.24. Webflow, Inc.
• 15.25. Yaskawa Electric Corporation